India
· Delayed Price · Currency is INR Cipla Company Description
Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally.
The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry.
The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
| Country | India |
| Founded | 1935 |
| Industry | Pharmaceutical Preparations |
| Employees | 27,764 |
| CEO | Umang Vohra |
Contact Details
Address: Cipla House Mumbai, 400013 India | |
| Phone | 91 22 2482 6000 |
| Website | cipla.com |
Stock Details
| Ticker Symbol | 500087 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Umang Vohra | Chief Executive Officer |
| Ashish Adukia | Chief Financial Officer |
| Diksha Maheshwari | Head of Investor Relations |